HIV treatment cascade in migrants and mobile populations

Current Opinion in HIV and AIDS

Volumn 10, Issue 6, 2015, Pages 430-438

  Tanser, Frank ^a   Bärnighausen, Till ^a,b   Vandormael, Alain ^a   Dobra, Adrian ^c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiretroviral therapy; HIV epidemiology; Key populations; Migration

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CONFUSION; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; META ANALYSIS (TOPIC); MIGRANT; NONHUMAN; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOCIAL ISOLATION; TRAVEL; VULNERABLE POPULATION; DISEASE TRANSMISSION; DRUG MONITORING; HEALTH CARE DELIVERY; HIV INFECTIONS; MIGRATION; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; PROCEDURES;

ANTI-RETROVIRAL AGENTS; DELIVERY OF HEALTH CARE; DISEASE TRANSMISSION, INFECTIOUS; DRUG MONITORING; HIV INFECTIONS; HUMANS; TRANSIENTS AND MIGRANTS;

EID: 84943768010     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000192     Document Type: Review

References (89)

1. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
2. Anglemyer A, Horvath T, Rutherford G. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. JAMA 2013; 310:1619-1620.
3. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339:966-971.
4. Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013; 339:961-965.
5. Herbst AJ, Cooke GS, Barnighausen T, et al. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ 2009; 87:754-762.
6. UNAIDS. How AIDS changed everything: MDG6-15 years, 15 lessons of hope from the AIDS response. Geneva: UNAIDS, 2015.
7. DoHHS. HIV Care Continuum. Department of Health and Human Services; 2013. https://aids.gov/federal-resources/policies/care-continuum/
8. Miller WC, Lesko CR, Powers KA. The HIV care cascade: simple concept, complex realization. Sex Transm Dis 2014; 41:41-42.
9. World Health Organization. Global update on HIV treatment 2013: results, impact and opportunities. Geneva: WHO, 2013
10. UNAIDS. UNAIDS Report on the global AIDS epidemic. Geneva: UNAIDS, 2013.
11. Mugglin C, Estill J, Wandeler G, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub Saharan Africa: systematic review and meta analysis. Trop Med Int Health 2012; 17:1509-1520.
12. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascadeofcare in the United States: exaggerated health disparities. AIDS Patient Care STDS 2014; 28:128-135.
13. Fox MP, Rosen S. Retention of adult patients on antiretroviral therapy in low-and middle-income countries: systematic review and meta-analysis 2008-2013. J Acquir Immune Defic Syndr 2015; 69:98-108.
14. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. Aids 2012; 26:2039-2052.
15. Wilkinson LS, Skordis-Worrall J, Ajose O, Ford N. Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low-and middle-income countries: systematic review and meta-analysis. Trop Med Int Health 2015; 20:365-379.
16. Taylor BS, Reyes EV, Levine EA, et al. Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherence. AIDS Patient Care STDS 2014; 28:284-295.
17. Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS 2013; 8:59-64.
18. Chen NE, Gallant JE, Page KR. A systematic review of HIV/AIDS survival and delayed diagnosis among Hispanics in the United States. J Immigr Minor Health 2012; 14:65-81.
19. Saracino A, Tartaglia A, Trillo G, et al. Late presentation and loss to follow-up of immigrants newly diagnosed with HIV in the HAART era. J Immigr Minor Health 2014; 16:751-755.
20. USC Bureau. American community survey, 2006-2010. US Census Bureau Washington, DC; 2013.
21. Johnson AS, Hu X, Dean HD. Epidemiologic differences between native-born and foreign-born black people diagnosed with HIV infection in 33 US states, 2001-2007. Public Health Rep 2010; 125 (Suppl 4):61.
22. World Health Organization. How health systems can address health inequities linked to migration and ethnicity. WHO Regional Office for Europe: Copenhagen, Denmark; 2010.
23. Vandormael A, Newell M-L, Bärnighausen T, Tanser F. Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-12: a prospective cohort study. Lancet Global Health 2014; 2:e209-e215.
24. Bärnighausen T, Hosegood V, Timaeus IM, Newell ML. The socioeconomic determinants of HIV incidence: evidence from a longitudinal, population based study in rural South Africa. Aids 2007; 21 (Suppl 7):S29-S38.
25. Lurie MN, Williams BG. Migration and Health in Southern Africa: 100 years and still circulating. Health Psychol Behav Med 2014; 2:34-40.
26. Lurie MN, Williams BG, Zuma K, et al. The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners. Sex Transm Dis 2003; 30:149-156.
27. UNAIDS. The GAP Report 2014. Geneva:UNAIDS, 2014.
28. Lima V, Fernandes K, Rachlis B, et al. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients. Soc Sci Med 2009; 68:1044-1049.
29. Bygrave H, Kranzer K, Hilderbrand K, et al. Trends in loss to follow-up among migrant workers on antiretroviral therapy in a community cohort in Lesotho. PLoS ONE 2010; 5:e13198.
30. Kagee A, Remien RH, Berkman A, et al. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Global Public Health 2011; 6:83-97.
31. Krentz HB, Worthington H, Gill MJ. Adverse health effects for individuals who move between HIV care centers. J Acquir Immune Defic Syndr 2011; 57:51-54.
32. Andrews JR, Wood R, Bekker L-G, et al. Projecting the benefits of antire-troviral therapy for HIV prevention: the impact of population mobility and linkage to care. J Infec Dis 2012; 206:543-551.
33. Abgrall S, Fugon L, Le'le' N, et al. Visiting one's native country: the risks of nonadherence in HIV-infected sub-Saharan Migrants-ANRS VIHVO Study. J Int Assoc Provid AIDS Care 2013; 12:407-413.
34. Ware NC, Wyatt MA, Geng EH, et al. Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLoS Medicine 2013; 10:e1001369.
35. Mann M, Lurie MN, Kimaiyo S, Kantor R. Effects of political conflict-induced treatment interruptions on HIV drug resistance. AIDS Rev 2013; 15:15-24.
36. Mutevedzi PC, Lessells RJ, Newell ML. Disengagement from care in a decentralised primary healthcare antiretroviral treatment programme: cohort study in rural South Africa. Trop Med Int Health 2013; 18:934-941.
37. Buskin SE, Kent JB, Dombrowski JC, Golden MR. Migration distorts surveillance estimates of engagement in care: results of public health investigations of persons who appear to be out of HIV care. Sex Transm Dis 2014; 41: 35-40.
38. Levira F, Todd J, Masanja H. Coming home to die? The association between migration and mortality in rural Tanzania before and after ART scale-up. Glob Health Action 2014; 7:22956.
39. Mendelsohn JB, Schilperoord M, Spiegel P, et al. Is forced migration a barrier to treatment success? Similar HIV treatment outcomes among refugees and a surrounding host community in Kuala Lumpur, Malaysia. AIDS Behav 2014; 18:323-334.
40. Hallett TB, Eaton JW. A side door into care cascade for HIV-infected patients? JAIDS 2013; 63:S228-S232.
41. Blondell SJ, Kitter B, Griffin MP, Durham J. Barriers and facilitators to HIV testing in migrants in high-income countries: a systematic review. AIDS Behav 2015; 1-13.
42. Ojikutu B, Nnaji C, Sithole J, et al. All black people are not alike: differences in HIV testing patterns, knowledge, and experience of stigma between US-born and non-US-born blacks in Massachusetts. AIDS Patient Care STDS 2013; 27:45-54.
43. Ojikutu B, Nnaji C, Sithole-Berk J, et al. Barriers to HIV testing in black immigrantsto the US. J Healthcare Poor Underserved 2014; 25:1052-1066.
44. Schulden JD, Painter TM, Song B, et al. HIV testing histories and risk factors among migrants and recent immigrants who received rapid HIV testing from three community-based organizations. J Immigr Minor Health 2014; 16:798-810.
45. Tiittala PJ, Kivela PS, Ristola MA, et al. Achieving high acceptability of HIV testing in a population-based survey among immigrants in Finland. Scand J Public Health 2015; 43:393-398.
46. Dworkin MS, Douglas G, Rani GS, Chakraborty A. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups. Int J STD AIDS 2015. [Epub ahead of print]
47. Ndadziyira P, Samupindi SI, Vuta C, et al. The impact of participant mobility on missed visits among women taking part in the VOICE (MTN-003) study in Zimbabwe. AIDS Res Hum Retroviruses 2014; 30 (Suppl 1):A170-A171.
48. Lindkvist P, Johansson E, Hylander I. Fogging the issue of HIV: barriers for HIV testing in a migrated population from Ethiopia and Eritrea. BMC Public Health 2015; 15:82.
49. Martinez-Donate AP, Rangel MG, Rhoads N, et al. Identifying opportunities to increase HIV testing among Mexican migrants: a call to step up efforts in healthcare and detention settings. PLoS One 2015; 10:e0123631.
50. Alvarez-del Arco D, Monge S, Caro-Murillo AM, et al. HIV testing policies for migrants and ethnic minorities in EU/EFTA member states. Eur J Public Health 2014; 24:139-144.
51. Mack N, Odhiambo J, Wong CM, Agot K. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders. BMC Health Serv Res 2014; 14:231.
52. Alvarez-del Arco D, Monge S, Azcoaga A, et al. HIV testing and counselling for migrant populations living in high-income countries: a systematic review. Eur J Public Health 2013; 23:1039-1045.
53. Gilbert PA, Rhodes SD. HIV testing among immigrant sexual and gender minority Latinos in a US region with little historical Latino presence. AIDS Patient Care STDS 2013; 27:628-636.
54. Burns F, Imrie JY, Nazroo J, et al. Why the (y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain. AIDS Care 2007; 19:102-108.
55. Prost A, Elford J, Imrie J, et al. Social, behavioural, and intervention research among people of Sub-Saharan African origin living with HIV in the UK and Europe: literature review and recommendations for intervention. AIDS Behav 2008; 12:170-194.
56. Campbell RM, Klei A, Hodges BD, et al. A comparison of health access between permanent residents, undocumented immigrants and refugee claimants in Toronto. Can J Immigr Minor Health 2014; 16:165-176.
57. Huang ZJ, Wong FY, De Leon JM, Park RJ. Self-reported HIV testing behaviors among a sample of Southeast Asians in an urban setting in the United States. AIDS Edu Prevent 2008; 20:65-77.
58. Vissman AT, Eng E, Aronson RE, et al. What do men who serve as lay health advisers really do? Immigrant Latino men share their experiences as Nave-gantes to prevent HIV. AIDS Edu Prevent 2009; 21:220-232.
59. Pérez-Molina JA, López Vélez R, Navarro M, et al. Clinicoepidemiological characteristics of-HIV infected immigrants attended at a tropical medicine referral unit. J Travel Med 2009; 16:248-252.
60. Jia Y, Sengupta D, Opoku J, et al. Site migration in seeking care services from multiple providers is associated with worse clinical outcomes among HIV-infected individuals in Washington. DC AIDS Care 2014; 26:1346-1351.
61. Veary J. Healthy migration: a public health and development imperative for south(ern) Africa. S Afr Med J 2014; 104:663-664.
62. Woolley I, Bailey C. Visiting friends and relatives may be a risk for non-adherence for HIV-positive travellers. Int J STD AIDS 2012; 23:833-834.
63. Kagee A, Steel H, Coetzee B. The relationship between structural barriers to adherence to antiretroviral therapy, psychological distress, and health-related quality of life. S Afr J Psychol 2014; 44:170-179.
64. Trepka MJ, Fennie KP, Pelletier V, et al. Migration patterns among Floridians with AIDS, 1993-2007: implications for HIV prevention and care. Migration 2014; 107:.
65. Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of healthcare providers. AIDS Care 2011; 23:146-151.
66. Portelli MS, Tenni B, Kounnavong S, Chanthivilay P. Barriers to and facilitators of adherence to antiretroviral therapy among people living with HIV in Lao PDR a qualitative study. Asia Pac J Public Health 2015; 27:N778-N788.
67. Suphanchaimat R, Sommanustweechai A, Khitdee C, et al. HIV/AIDS healthcare challenges for cross-country migrants in low-and middle-income countries: a scoping review. HIV/AIDS (Auckland, NZ) 2014; 6:19.
68. Chaplin B, Meloni S, Eisen G, et al. Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system. Int J Med Inform 2015; 84:58-68.
69. Fraser HSF, Biondich P, Moodley D, et al. Implementing electronic medical record systems in developing countries. Inform Prim Care 2005; 13:83-95.
70. Oluoch T, Katana A, Ssempijja V, et al. Electronic medical record systems are associated with appropriate placement of HIV patients on antiretroviral therapy in rural health facilities in Kenya: a retrospective prepost study. J Am Med Inform Assoc 2014; 21:1009-1014.
71. Oluoch T, Kwaro D, Ssempijja V, et al. Better adherence to preantiretroviral therapy guidelines after implementing an electronic medical record system in rural Kenyan HIV clinics: a multicenter pre-post study. Int J Infect Dis 2015; 33:109-113.
72. Rowan SE, Burman WJ, Johnson SC, et al. Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city. AIDS Patient Care STDS 2014; 28:475-482.
73. International Telecommunication Union (ITU). International Telecommunication Union Facts and Figures. International Telecommunication Union; 2015. http://www.itu.int/en/ITU-D/Statistics/Pages/facts/default.aspx
74. Bärnighausen T, Chaiyachati K, Chimbindi N, et al. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 11:942-951.
75. Chaiyachati KH, Ogbuoji O, Price M, et al. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS 2014; 28 (Suppl 2): S187-S204.
76. Mbuagbaw L, Thabane L, Ongolo-Zogo P, et al. The Cameroon Mobile Phone SMS (CAMPS) Trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS ONE 2012; 7:e46909.
77. Catalani C, Philbrick W, Fraser H, et al. mHealth for HIV treatment & prevention: a systematic review of the literature. Open AIDS J 2013; 7:17-41.
78. Lester RT. Ask, don't tell-mobile phones to improve HIV care. N Engl J Med 2013; 369:1867-1868.
79. Mbuagbaw L, Thabane L, Ongolo-Zogo P. Opening communication channels with people living with HIV using mobile phone text messaging: insights from the CAMPS trial. BMC Res Notes 2013; 6:.
80. Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health 2014; 14:188.
81. Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One 2014; 9:e88166.
82. Belzer ME, MacDonell KK, Clark LF, et al. Acceptability and feasibility of a cell phone support intervention for youth living with HIV with nonadherence to antiretroviral therapy. AIDS Patient Care STDS 2015; 29:1-8.
83. The Global Fund. Scalingup antiretroviral therapyinglobal fund: concept notes. 2015. www.theglobalfund.org/../infonotes/Core-ARTScaleUp-InfoNote-en/
84. Govindasamy D, Meghij J, Negussi EK, et al. Interventions to improve or facilitate linkage toor retention inpre-ART (HIV) care and initiationofART inlow-and middle-income settings- A systematic review. J Int AIDS Soc 2014; 17.
85. Sheehan DM, Trepka MJ, Dillon FR. Latinos in the United States on the HIV/AIDS care continuum by birth country/region: a systematic review of the literature. Int J STD AIDS 2015; 26:1-12.
86. Priebe S, Bogic M, Ádány R, et al. Good practice in emergency care: views from practitioners. Migration and health in the European Union 2011; 213-226.
87. World Health Organization (WHO). Health of migrants-the way forward: report of a global consultation. Geneva: World Health Organization; 2010.
88. Rechel B, Mladovsky P, Devillé W, et al. Migration and health in the European Union: an introduction. European Observatory on Health Systems and Policies Series; 2011.
89. Messina A. Asylum, residency and citizenship policies and models of migrant incorporation. In: Rechel B, Mladovsky P, Devillé W, et al., editors. Migration and health in the European Union. McGraw Hill; 2011.